\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ ruq\\ us\\ \\(films\\ \\.1\\ and\\ \\.2\\)\\ reveals\\ a\\ large\\ gallstone\\ casting\\ an\\ acoustic\\ shadow\\.\\ \\ the\\ gb\\ lumen\\ is\\ not\\ well\\-identified\\.\\ \\ there\\ is\\ an\\ area\\ of\\ increased\\ echogenicity\\ posterior\\ to\\ the\\ gallbladder\\ suspicious\\ for\\ a\\ mass\\.\\ \\ the\\ ct\\ \\(film\\ \\.3\\)\\ demonstrates\\ dilated\\ intrahepatic\\ ducts\\,\\ no\\ dilated\\ extrahepatic\\ ducts\\,\\ and\\ a\\ mass\\ partially\\ replacing\\ the\\ gb\\ lumen\\ and\\ extending\\ into\\ the\\ liver\\ posteromedially\\.\\ \\ lower\\ cuts\\ show\\ a\\ round\\ hypodensity\\ in\\ the\\ gb\\ \\(arrow\\)\\ representing\\ a\\ large\\ non\\-calcified\\ gallstone\\.\\ \\ note\\ the\\ mass\\ effect\\ against\\ the\\ contrast\\-filled\\ duodenum\\.\\ \\ a\\ ptc\\ was\\ done\\ next\\ to\\ better\\ define\\ the\\ extent\\ of\\ ductal\\ involvement\\ \\(film\\ \\.4\\)\\.\\ \\ the\\ films\\ show\\ high\\ grade\\ obstruction\\ of\\ the\\ chd\\ near\\ the\\ hilus\\ with\\ medial\\ displacement\\ of\\ the\\ duct\\ by\\ adjacent\\ tumor\\ mass\\.\\ \\ the\\ intrahepatic\\ ducts\\ are\\ markedly\\ dilated\\.\\ \\ the\\ findings\\ of\\ a\\ mass\\ partially\\ filling\\ the\\ gallbladder\\ lumen\\ and\\ extending\\ into\\ the\\ liver\\ with\\ ductal\\ obstruction\\ at\\ level\\ of\\ the\\ porta\\ hepatis\\ and\\ the\\ presence\\ of\\ a\\ gallstone\\ are\\ characteristic\\ of\\ gallbladder\\ carcinoma\\.\\ \\ this\\ diagnosis\\ was\\ surgically\\ confirmed\\.\ \(0\)\
\-\ two\\ additional\\ cases\\ of\\ gallbladder\\ carcinoma\\ demonstrating\\ characteristic\\ findings\\ on\\ imaging\\ studies\\ are\\ included\\.\\ \\ a\\ ct\\ scan\\ \\(film\\ \\.5\\)\\ from\\ a\\ patient\\ with\\ tumor\\ replacing\\ the\\ gallbladder\\ lumen\\ \\(hu\\ \\#31\\)\\ and\\ locally\\ invading\\ the\\ liver\\ is\\ shown\\.\\ \\ note\\ the\\ irregular\\ margins\\,\\ a\\ large\\ mass\\ in\\ the\\ gallbladder\\ fossa\\ and\\ the\\ presence\\ of\\ calcified\\ gallstones\\ \\(arrow\\)\\.\\ \\ us\\ \\(films\\ \\.6\\ and\\ \\.7\\)\\ and\\ ct\\ \\(film\\ \\.8\\)\\ from\\ the\\ other\\ case\\ show\\ thickening\\ of\\ the\\ gallbladder\\ wall\\ with\\ a\\ polypoid\\ intraluminal\\ mass\\.\\ \\ extension\\ into\\ the\\ adjacent\\ liver\\ and\\ multiple\\ small\\ hepatic\\ metastases\\ are\\ visible\\ on\\ the\\ ct\\.\ \(0\)\
\-\ gallbladder\\ carcinoma\\.\ \(2\)\
\-\ a\\ 69\\-year\\-old\\ woman\\ with\\ ruq\\ pain\\,\\ weight\\ loss\\ and\\ jaundice\\,\\ was\\ admitted\\ for\\ evaluation\\.\\ \\ she\\ was\\ examined\\ with\\ us\\ and\\ ct\\.\\ \\ what\\ are\\ the\\ findings\\?\\ \\ what\\ would\\ you\\ do\\ next\\?\ \(0\)\
\-\ carcinoma\\ of\\ the\\ gallbladder\\ is\\ the\\ fifth\\ most\\ common\\ cause\\ of\\ death\\ from\\ gi\\ malignancy\\.\\ \\ most\\ cases\\ occur\\ after\\ the\\ age\\ of\\ 50\\.\\ \\ gallbladder\\ carcinoma\\ is\\ three\\ times\\ more\\ frequent\\ in\\ females\\.\\ \\ there\\ is\\ a\\ high\\ association\\ \\(65\\-95\\%\\)\\ with\\ gallstones\\.\\ \\ the\\ disease\\ is\\ almost\\ always\\ advanced\\ at\\ the\\ time\\ of\\ detection\\;\\ the\\ early\\ stages\\ are\\ asymptomatic\\.\\ \\ it\\ may\\ be\\ an\\ incidental\\ finding\\ at\\ cholecystectomy\\ or\\ on\\ imaging\\ studies\\.\ \(0\)\
\-\ most\\ lesions\\ are\\ well\\-differentiated\\ adenocarcinoma\\.\\ \\ three\\ primary\\ morphologic\\ patterns\\ are\\ seen\\ \\(film\\ \\.9\\)\\:\\ \\ 1\\)\\ an\\ intraluminal\\ polypoid\\ mass\\ \\(15\\-25\\%\\)\\,\\ \\ 2\\)\\ focal\\ or\\ diffuse\\ wall\\ thickening\\ \\(20\\-30\\%\\)\\,\\ and\\ \\ 3\\)\\ a\\ fungating\\ mass\\ replacing\\ the\\ gallbladder\\ \\(40\\-65\\%\\)\\ and\\ extending\\ to\\ the\\ adjacent\\ liver\\.\\ \ \(0\)\
\-\ direct\\ spread\\ to\\ contiguous\\ structures\\ is\\ the\\ most\\ frequent\\ route\\ of\\ extension\\ and\\ involvement\\ of\\ the\\ medial\\ segment\\ of\\ the\\ left\\ lobe\\ of\\ the\\ liver\\ is\\ most\\ commonly\\ seen\\.\\ \\ biliary\\ obstruction\\ is\\ common\\.\ \(0\)\
\-\ the\\ preoperative\\ diagnosis\\ was\\ rarely\\ made\\ prior\\ to\\ ultrasound\\ and\\ ct\\;\\ ocg\\ showed\\ non\\-visualization\\.\\ \\ on\\ us\\ and\\ ct\\,\\ the\\ most\\ frequent\\ findings\\ are\\ gallstones\\ and\\ a\\ mass\\ in\\ the\\ gallbladder\\ fossa\\ extending\\ to\\ the\\ adjacent\\ liver\\.\\ \\ this\\ appearance\\ may\\ be\\ difficult\\ to\\ distinguish\\ from\\ cholecystitis\\ complicated\\ by\\ abscess\\ or\\ perforation\\.\\ \\ dilated\\ bile\\ ducts\\ from\\ tumor\\ involvement\\ and\\ obstruction\\ of\\ the\\ chd\\ may\\ also\\ be\\ seen\\.\\ \\ other\\ findings\\ seen\\ on\\ us\\ or\\ ct\\ include\\ gallbladder\\ wall\\ thickening\\,\\ an\\ intraluminal\\ polypoid\\ mass\\,\\ nodal\\ involvement\\ or\\ metastases\\.\\ \\ when\\ the\\ mass\\ is\\ confined\\ to\\ the\\ gallbladder\\,\\ the\\ sonographic\\ appearance\\ may\\ be\\ indistinguishable\\ from\\ gallstones\\ or\\ the\\ presence\\ of\\ stones\\ may\\ obscure\\ the\\ lesion\\.\ \(0\)\
\-\ when\\ biliary\\ obstruction\\ is\\ present\\,\\ direct\\ cholangiography\\ is\\ helpful\\ to\\ outline\\ the\\ exact\\ nature\\ and\\ site\\ of\\ obstruction\\.\\ \\ this\\ may\\ be\\ difficult\\ to\\ assess\\ by\\ ct\\ or\\ us\\.\\ \\ on\\ ptc\\,\\ the\\ common\\ hepatic\\ duct\\ above\\ the\\ cystic\\ in\\ the\\ area\\ of\\ the\\ porta\\ hepatis\\ is\\ most\\ frequently\\ affected\\.\\ \\ the\\ common\\ duct\\ may\\ be\\ displaced\\ medially\\ by\\ the\\ tumor\\ mass\\.\\ \\ if\\ the\\ lesion\\ extends\\ higher\\ into\\ the\\ liver\\,\\ multiple\\ sites\\ of\\ obstruction\\ can\\ be\\ present\\.\\ \\ because\\ of\\ cystic\\ duct\\ involvement\\,\\ the\\ gallbladder\\ usually\\ does\\ not\\ fill\\.\\ \\ the\\ differential\\ diagnosis\\ of\\ the\\ cholangiographic\\ appearance\\ includes\\ obstruction\\ from\\ metastatic\\ nodes\\ in\\ the\\ porta\\ hepatis\\ and\\ primary\\ cholangiocarcinoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gallbladder\\:\\ 0\\.08256008490591484\ \(0\)\
\-\ obstruction\\:\\ 0\\.03231528202240681\ \(0\)\
\-\ liver\\:\\ 0\\.0315948687488764\ \(0\)\
\-\ us\\:\\ 0\\.028829033301168188\ \(0\)\
\-\ gallstones\\:\\ 0\\.02790670515454302\ \(0\)\
\-\ hepatis\\:\\ 0\\.026615122707628464\ \(0\)\
\-\ ducts\\:\\ 0\\.02629220063559438\ \(0\)\
\-\ gb\\:\\ 0\\.025808135996654668\ \(0\)\
\-\ porta\\:\\ 0\\.025808135996654668\ \(0\)\
\-\ replacing\\:\\ 0\\.024301325878257573\ \(0\)\
\-\ ptc\\:\\ 0\\.023634097651384713\ \(0\)\
\-\ chd\\:\\ 0\\.023634097651384713\ \(0\)\
\-\ polypoid\\:\\ 0\\.023403965752329118\ \(0\)\
\-\ gallstone\\:\\ 0\\.0228419204076569\ \(0\)\
\-\ lumen\\:\\ 0\\.022064547228815453\ \(0\)\
\-\ film\\:\\ 0\\.021998183212057494\ \(0\)\
\-\ duct\\:\\ 0\\.02100631969981548\ \(0\)\
\-\ involvement\\:\\ 0\\.020991545955950514\ \(0\)\
\-\ mass\\:\\ 0\\.02071044650176721\ \(0\)\
\-\ intraluminal\\:\\ 0\\.019484825108905\ \(0\)\
\-\ most\\:\\ 0\\.018511857898252722\ \(0\)\
\-\ may\\:\\ 0\\.017587531611644593\ \(0\)\
\-\ frequent\\:\\ 0\\.017180524028270087\ \(0\)\
\-\ arrow\\:\\ 0\\.016757557819048155\ \(0\)\
\-\ dilated\\:\\ 0\\.016649283681456455\ \(0\)\
\-\ \\)\\:\\ 0\\.016260242313573977\ \(0\)\
\-\ carcinoma\\:\\ 0\\.016232759182411974\ \(0\)\
\-\ extending\\:\\ 0\\.015403319296728136\ \(0\)\
\-\ adjacent\\:\\ 0\\.01448705760929902\ \(0\)\
\-\ ct\\:\\ 0\\.014420553459153333\ \(0\)\
\-\ films\\:\\ 0\\.014184657077501193\ \(0\)\
\-\ are\\:\\ 0\\.014053438140437554\ \(0\)\
\-\ \\(\\:\\ 0\\.013556386283396846\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.013488817131496614\ \(0\)\
\-\ ruq\\:\\ 0\\.012890577047544309\ \(0\)\
\-\ presence\\:\\ 0\\.012473668706932155\ \(0\)\
\-\ be\\:\\ 0\\.012365009468374669\ \(0\)\
\-\ findings\\:\\ 0\\.012190596084383108\ \(0\)\
\-\ what\\:\\ 0\\.012095049144134928\ \(0\)\
\-\ the\\:\\ 0\\.012045849203399031\ \(0\)\
\-\ common\\:\\ 0\\.011990708911294355\ \(0\)\
\-\ from\\:\\ 0\\.011883445029597166\ \(0\)\
\-\ well\\-identified\\:\\ 0\\.011817048825692357\ \(0\)\
\-\ 69\\-year\\-old\\:\\ 0\\.011817048825692357\ \(0\)\
\-\ 65\\-95\\:\\ 0\\.011817048825692357\ \(0\)\
\-\ cholangiographic\\:\\ 0\\.011817048825692357\ \(0\)\
\-\ thickening\\:\\ 0\\.01164862427490624\ \(0\)\
\-\ next\\:\\ 0\\.011630513698360032\ \(0\)\
\-\ biliary\\:\\ 0\\.011570264755056925\ \(0\)\
\-\ into\\:\\ 0\\.010902554251794675\ \(0\)\
\-\ \\.5\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ \\.6\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ \\.7\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ \\.9\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ 40\\-65\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ ocg\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ cholangiography\\:\\ 0\\.010887897109124066\ \(0\)\
\-\ direct\\:\\ 0\\.010821434130978469\ \(0\)\
\-\ ductal\\:\\ 0\\.010798999145266629\ \(0\)\
\-\ \\%\\:\\ 0\\.010688048436171623\ \(0\)\
\-\ tumor\\:\\ 0\\.010682210732497647\ \(0\)\
\-\ is\\:\\ 0\\.010552373857086003\ \(0\)\
\-\ show\\:\\ 0\\.010548884455060158\ \(0\)\
\-\ partially\\:\\ 0\\.010483226931710641\ \(0\)\
\-\ contrast\\-filled\\:\\ 0\\.010344378197450923\ \(0\)\
\-\ \\.8\\:\\ 0\\.010344378197450923\ \(0\)\
\-\ non\\-visualization\\:\\ 0\\.010344378197450923\ \(0\)\
\-\ difficult\\:\\ 0\\.01002773353547633\ \(0\)\
\-\ posteromedially\\:\\ 0\\.009958745392555774\ \(0\)\
\-\ hilus\\:\\ 0\\.009958745392555774\ \(0\)\
\-\ 15\\-25\\:\\ 0\\.009958745392555774\ \(0\)\
\-\ wall\\:\\ 0\\.009953723003641071\ \(0\)\
\-\ appearance\\:\\ 0\\.009828042533785422\ \(0\)\
\-\ metastases\\:\\ 0\\.009787486461241245\ \(0\)\
\-\ characteristic\\:\\ 0\\.009697108291422715\ \(0\)\
\-\ 50\\.\\:\\ 0\\.009659625350579622\ \(0\)\
\-\ hepatic\\:\\ 0\\.0095670089860751\ \(0\)\
\-\ or\\:\\ 0\\.00939766654523586\ \(0\)\
\-\ fossa\\:\\ 0\\.009337264425472195\ \(0\)\
\-\ fungating\\:\\ 0\\.009208590180846092\ \(0\)\
\-\ seen\\:\\ 0\\.009054303566046596\ \(0\)\
\-\ \\.3\\:\\ 0\\.009029593675987484\ \(0\)\
\-\ \\.4\\:\\ 0\\.009029593675987484\ \(0\)\
\-\ morphologic\\:\\ 0\\.009029593675987484\ \(0\)\
\-\ \\?\\:\\ 0\\.008940695712130044\ \(0\)\
\-\ note\\:\\ 0\\.008841998733248767\ \(0\)\
\-\ \\.1\\:\\ 0\\.00873047363401133\ \(0\)\
\-\ cuts\\:\\ 0\\.00873047363401133\ \(0\)\
\-\ well\\-differentiated\\:\\ 0\\.00873047363401133\ \(0\)\
\-\ obscure\\:\\ 0\\.00873047363401133\ \(0\)\
\-\ outline\\:\\ 0\\.00873047363401133\ \(0\)\
\-\ non\\-calcified\\:\\ 0\\.00860271199888489\ \(0\)\
\-\ studies\\:\\ 0\\.008556302728630455\ \(0\)\
\-\ a\\:\\ 0\\.00850616196929976\ \(0\)\
\-\ \\.2\\:\\ 0\\.00848607476431434\ \(0\)\
\-\ indistinguishable\\:\\ 0\\.008378778909524078\ \(0\)\
\-\ route\\:\\ 0\\.0082794384642778\ \(0\)\
\-\ extension\\:\\ 0\\.00817782123641194\ \(0\)\
\-\ 20\\-30\\:\\ 0\\.007942555852641198\ \(0\)\
\-\ an\\:\\ 0\\.007920005792793096\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007890962456221527\ \(0\)\
\-\ locally\\:\\ 0\\.007870079684718577\ \(0\)\
\-\ three\\:\\ 0\\.007722853159106998\ \(0\)\
\-\ define\\:\\ 0\\.007673560282316598\ \(0\)\
\-\ nodal\\:\\ 0\\.007673560282316598\ \(0\)\
\-\ cases\\:\\ 0\\.007632200707724216\ \(0\)\
\-\ by\\:\\ 0\\.007629334601849194\ \(0\)\
\-\ invading\\:\\ 0\\.007613973469218966\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.0075569230477460485\ \(0\)\
\-\ large\\:\\ 0\\.0075142457044145294\ \(0\)\
\-\ fill\\:\\ 0\\.0075022018754668865\ \(0\)\
\-\ hu\\:\\ 0\\.0073990369409680555\ \(0\)\
\-\ medial\\:\\ 0\\.007327880733485394\ \(0\)\
\-\ patterns\\:\\ 0\\.007303247445013436\ \(0\)\
\-\ area\\:\\ 0\\.00724352880464951\ \(0\)\
\-\ examined\\:\\ 0\\.0072138488196800965\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.0072138488196800965\ \(0\)\
\-\ exact\\:\\ 0\\.007090023993767207\ \(0\)\
\-\ hypodensity\\:\\ 0\\.007051166705733357\ \(0\)\
\-\ preoperative\\:\\ 0\\.007013404136072907\ \(0\)\
\-\ distinguish\\:\\ 0\\.006976676288635755\ \(0\)\
\-\ confined\\:\\ 0\\.006906108281282643\ \(0\)\
\-\ stages\\:\\ 0\\.006872170200874748\ \(0\)\
\-\ jaundice\\:\\ 0\\.006839070183997574\ \(0\)\
\-\ primary\\:\\ 0\\.006786552983634575\ \(0\)\
\-\ casting\\:\\ 0\\.006775225614306884\ \(0\)\
\-\ detection\\:\\ 0\\.006655993059324987\ \(0\)\
\-\ you\\:\\ 0\\.006627771331177758\ \(0\)\
\-\ was\\:\\ 0\\.006623843982665461\ \(0\)\
\-\ cystic\\:\\ 0\\.006607594389414902\ \(0\)\
\-\ contiguous\\:\\ 0\\.006600131535999827\ \(0\)\
\-\ when\\:\\ 0\\.006561209752321731\ \(0\)\
\-\ shadow\\:\\ 0\\.006520475476387494\ \(0\)\
\-\ medially\\:\\ 0\\.006520475476387494\ \(0\)\
\-\ acoustic\\:\\ 0\\.006421135031141218\ \(0\)\
\-\ against\\:\\ 0\\.006421135031141218\ \(0\)\
\-\ females\\:\\ 0\\.006374095728445147\ \(0\)\
\-\ fifth\\:\\ 0\\.006284697103111805\ \(0\)\
\-\ high\\:\\ 0\\.006269560485460632\ \(0\)\
\-\ sites\\:\\ 0\\.006242138526282609\ \(0\)\
\-\ duodenum\\:\\ 0\\.006200889654075164\ \(0\)\
\-\ death\\:\\ 0\\.006180731641522162\ \(0\)\
\-\ echogenicity\\:\\ 0\\.006160872277198916\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.006122014989165066\ \(0\)\
\-\ bile\\:\\ 0\\.006122014989165066\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.006084252419504615\ \(0\)\
\-\ 31\\:\\ 0\\.006011776251581994\ \(0\)\
\-\ complicated\\:\\ 0\\.0059430184843064565\ \(0\)\
\-\ helpful\\:\\ 0\\.005926366312726621\ \(0\)\
\-\ representing\\:\\ 0\\.005909918467429283\ \(0\)\
\-\ better\\:\\ 0\\.005909918467429283\ \(0\)\
\-\ always\\:\\ 0\\.005893669994865818\ \(0\)\
\-\ perforation\\:\\ 0\\.005893669994865818\ \(0\)\
\-\ stones\\:\\ 0\\.005893669994865818\ \(0\)\
\-\ advanced\\:\\ 0\\.005861752235222764\ \(0\)\
\-\ on\\:\\ 0\\.005822179724118724\ \(0\)\
\-\ surgically\\:\\ 0\\.0058001099922712586\ \(0\)\
\-\ assess\\:\\ 0\\.005741178191438662\ \(0\)\
\-\ to\\:\\ 0\\.0057247735716218\ \(0\)\
\-\ extent\\:\\ 0\\.005684728479173077\ \(0\)\
\-\ higher\\:\\ 0\\.005617353365525773\ \(0\)\
\-\ association\\:\\ 0\\.005565789986400042\ \(0\)\
\-\ times\\:\\ 0\\.005553203203089265\ \(0\)\
\-\ sonographic\\:\\ 0\\.005553203203089265\ \(0\)\
\-\ almost\\:\\ 0\\.005540733507831472\ \(0\)\
\-\ spread\\:\\ 0\\.005540733507831472\ \(0\)\
\-\ suspicious\\:\\ 0\\.005516136807203863\ \(0\)\
\-\ rarely\\:\\ 0\\.0054919833145729265\ \(0\)\
\-\ \\,\\:\\ 0\\.005443231880374411\ \(0\)\
\-\ \\;\\:\\ 0\\.005430083615154407\ \(0\)\
\-\ markedly\\:\\ 0\\.005422029221850983\ \(0\)\
\-\ visible\\:\\ 0\\.005422029221850983\ \(0\)\
\-\ nature\\:\\ 0\\.005422029221850983\ \(0\)\
\-\ imaging\\:\\ 0\\.005367490145993573\ \(0\)\
\-\ included\\:\\ 0\\.005281931770462931\ \(0\)\
\-\ other\\:\\ 0\\.005280532302151337\ \(0\)\
\-\ displaced\\:\\ 0\\.005261621039872312\ \(0\)\
\-\ margins\\:\\ 0\\.0052024725078227965\ \(0\)\
\-\ present\\:\\ 0\\.0051742862035701895\ \(0\)\
\-\ nodes\\:\\ 0\\.0051738490165753855\ \(0\)\
\-\ gi\\:\\ 0\\.005145823969900702\ \(0\)\
\-\ and\\:\\ 0\\.0050672776412554795\ \(0\)\
\-\ segment\\:\\ 0\\.00499721459615833\ \(0\)\
\-\ demonstrating\\:\\ 0\\.004972617895530721\ \(0\)\
\-\ do\\:\\ 0\\.004972617895530721\ \(0\)\
\-\ frequently\\:\\ 0\\.004964518278297527\ \(0\)\
\-\ extends\\:\\ 0\\.004964518278297527\ \(0\)\
\-\ near\\:\\ 0\\.004956467307707431\ \(0\)\
\-\ affected\\:\\ 0\\.004956467307707431\ \(0\)\
\-\ round\\:\\ 0\\.004948464402899784\ \(0\)\
\-\ admitted\\:\\ 0\\.004948464402899784\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.004948464402899784\ \(0\)\
\-\ calcified\\:\\ 0\\.004916922181170302\ \(0\)\
\-\ displacement\\:\\ 0\\.0049091512459366205\ \(0\)\
\-\ site\\:\\ 0\\.004841168548109521\ \(0\)\
\-\ multiple\\:\\ 0\\.004825217167504742\ \(0\)\
\-\ done\\:\\ 0\\.004748684806169908\ \(0\)\
\-\ lesion\\:\\ 0\\.004666367898124544\ \(0\)\
\-\ at\\:\\ 0\\.004655883992620508\ \(0\)\
\-\ includes\\:\\ 0\\.004617802139194149\ \(0\)\
\-\ filling\\:\\ 0\\.004611581791263181\ \(0\)\
\-\ additional\\:\\ 0\\.004593092083310988\ \(0\)\
\-\ shown\\:\\ 0\\.004593092083310988\ \(0\)\
\-\ irregular\\:\\ 0\\.004568829292903994\ \(0\)\
\-\ made\\:\\ 0\\.004562831598004636\ \(0\)\
\-\ \\#\\:\\ 0\\.004492877505282692\ \(0\)\
\-\ reveals\\:\\ 0\\.004481565348920943\ \(0\)\
\-\ malignancy\\:\\ 0\\.004426393669975223\ \(0\)\
\-\ structures\\:\\ 0\\.0044102754488401\ \(0\)\
\-\ grade\\:\\ 0\\.004363052001274759\ \(0\)\
\-\ incidental\\:\\ 0\\.0043375182278555975\ \(0\)\
\-\ commonly\\:\\ 0\\.0043224282083855784\ \(0\)\
\-\ confirmed\\:\\ 0\\.004307506170357637\ \(0\)\
\-\ occur\\:\\ 0\\.004297649636436379\ \(0\)\
\-\ above\\:\\ 0\\.004198309191190103\ \(0\)\
\-\ early\\:\\ 0\\.0041892211389308815\ \(0\)\
\-\ weight\\:\\ 0\\.00410582544925049\ \(0\)\
\-\ would\\:\\ 0\\.00407636310780441\ \(0\)\
\-\ of\\:\\ 0\\.004060454183307908\ \(0\)\
\-\ effect\\:\\ 0\\.00405570811403384\ \(0\)\
\-\ because\\:\\ 0\\.004007397207219904\ \(0\)\
\-\ does\\:\\ 0\\.003908339236439687\ \(0\)\
\-\ cause\\:\\ 0\\.00387568716695974\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0038721077721127176\ \(0\)\
\-\ this\\:\\ 0\\.0038651630562230553\ \(0\)\
\-\ showed\\:\\ 0\\.0037557684556617918\ \(0\)\
\-\ finding\\:\\ 0\\.003691771454475176\ \(0\)\
\-\ differential\\:\\ 0\\.003636675374467734\ \(0\)\
\-\ abscess\\:\\ 0\\.003621764402324755\ \(0\)\
\-\ age\\:\\ 0\\.003486474967217569\ \(0\)\
\-\ usually\\:\\ 0\\.0034784561043790336\ \(0\)\
\-\ diffuse\\:\\ 0\\.0034678383651143632\ \(0\)\
\-\ there\\:\\ 0\\.003409425084356538\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0033982876474615326\ \(0\)\
\-\ in\\:\\ 0\\.003389253861717868\ \(0\)\
\-\ evaluation\\:\\ 0\\.0033273978496337906\ \(0\)\
\-\ loss\\:\\ 0\\.0033250189979469697\ \(0\)\
\-\ not\\:\\ 0\\.003310505822364438\ \(0\)\
\-\ level\\:\\ 0\\.0033014598225830187\ \(0\)\
\-\ two\\:\\ 0\\.0032806048761608655\ \(0\)\
\-\ focal\\:\\ 0\\.0032714391476386085\ \(0\)\
\-\ time\\:\\ 0\\.003235390385039293\ \(0\)\
\-\ she\\:\\ 0\\.0032155310207160484\ \(0\)\
\-\ include\\:\\ 0\\.0032133424772523953\ \(0\)\
\-\ scan\\:\\ 0\\.003206798204333751\ \(0\)\
\-\ if\\:\\ 0\\.003108235165925785\ \(0\)\
\-\ lobe\\:\\ 0\\.0030822055602192145\ \(0\)\
\-\ lesions\\:\\ 0\\.0030664349950991258\ \(0\)\
\-\ prior\\:\\ 0\\.002941169935928101\ \(0\)\
\-\ metastatic\\:\\ 0\\.0028835246697266627\ \(0\)\
\-\ more\\:\\ 0\\.002864847599614164\ \(0\)\
\-\ increased\\:\\ 0\\.0028022584206429703\ \(0\)\
\-\ 1\\:\\ 0\\.002725638562948669\ \(0\)\
\-\ 3\\:\\ 0\\.0026822728240034044\ \(0\)\
\-\ woman\\:\\ 0\\.0026459825033363356\ \(0\)\
\-\ posterior\\:\\ 0\\.0026402661510756685\ \(0\)\
\-\ small\\:\\ 0\\.0026388408637816603\ \(0\)\
\-\ can\\:\\ 0\\.0025981532874920503\ \(0\)\
\-\ lower\\:\\ 0\\.0025762226130882876\ \(0\)\
\-\ it\\:\\ 0\\.0025748637862372877\ \(0\)\
\-\ case\\:\\ 0\\.0025060381137630974\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0025021731925645926\ \(0\)\
\-\ 2\\:\\ 0\\.0024666280114082387\ \(0\)\
\-\ after\\:\\ 0\\.0023699748024252044\ \(0\)\
\-\ also\\:\\ 0\\.002258203208673125\ \(0\)\
\-\ for\\:\\ 0\\.001954713535235161\ \(0\)\
\-\ \\.\\:\\ 0\\.0019510468900686292\ \(0\)\
\-\ disease\\:\\ 0\\.0018723023340693086\ \(0\)\
\-\ \\:\\:\\ 0\\.0015151136943574598\ \(0\)\
\-\ pain\\:\\ 0\\.0013989385623736392\ \(0\)\
\-\ left\\:\\ 0\\.0012816424521084648\ \(0\)\
\-\ no\\:\\ 0\\.0011534103896833807\ \(0\)\
\-\ patient\\:\\ 0\\.0011482465561881876\ \(0\)\
\-\ with\\:\\ 0\\.001097894413712102\ \(0\)\
